X4 Pharmaceuticals, Inc. (XFOR)
4.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
4.05
+0.01
(+0.25%)
After-Hours: 20:00
X4 Pharmaceuticals Cash and Short Term Investments (Quarterly) : 208.55M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 208.55M |
| March 31, 2026 | 233.72M |
| December 31, 2025 | 253.80M |
| September 30, 2025 | 122.42M |
| June 30, 2025 | 62.95M |
| March 31, 2025 | 86.95M |
| December 31, 2024 | 102.06M |
| September 30, 2024 | 134.98M |
| June 30, 2024 | 168.75M |
| March 31, 2024 | 80.87M |
| December 31, 2023 | 114.47M |
| September 30, 2023 | 141.93M |
| June 30, 2023 | 141.56M |
| March 31, 2023 | 93.66M |
| December 31, 2022 | 122.00M |
| September 30, 2022 | 79.86M |
| June 30, 2022 | 47.38M |
| March 31, 2022 | 66.43M |
| December 31, 2021 | 81.79M |
| September 30, 2021 | 76.39M |
| Date | Value |
|---|---|
| June 30, 2021 | 95.16M |
| March 31, 2021 | 114.94M |
| December 31, 2020 | 78.97M |
| September 30, 2020 | 88.81M |
| June 30, 2020 | 103.74M |
| March 31, 2020 | 115.05M |
| December 31, 2019 | 126.18M |
| September 30, 2019 | 76.25M |
| June 30, 2019 | 93.34M |
| March 31, 2019 | 22.30M |
| December 31, 2018 | 8.134M |
| September 30, 2018 | 40.80M |
| June 30, 2018 | 49.99M |
| March 31, 2018 | 64.05M |
| December 31, 2017 | 76.79M |
| September 30, 2017 | 31.37M |
| June 30, 2017 | 32.50M |
| March 31, 2017 | 3.877M |
| December 31, 2016 | 3.035M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 788.49M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Anixa Biosciences, Inc. | 13.69M |